Cardioprotective Mechanisms of Anti-Diabetic Agents - Evolution of the Outcomes Trial: an Industry Perspective
M. Angelyn Bethel, MD, FRCP
Eli Lilly & Co.
Please complete the form here or contact [email protected] to learn more about licensing content from the Endocrine Society.
If you believe you should have access to this media, please login.
